|
Name |
Chaetocin, 2-de(hydroxymethyl)-19'-deoxy-2-ethyl-6,6'-dihydroxy-, (6S,6'S,7S,7'S)-
|
Molecular Formula | C31H30N6O6S4 | |
IUPAC Name* |
(1S,2S,3R,11R)-3-[(1S,2S,3S,11S,14S)-14-ethyl-2-hydroxy-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.01,12.03,11.04,9]octadeca-4,6,8-trien-3-yl]-2-hydroxy-14,18-dimethyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.01,12.03,11.04,9]octadeca-4,6,8-triene-13,17-dione
|
|
SMILES |
CC[C@]12C(=O)N3[C@H]4[C@]([C@@H]([C@@]3(C(=O)N1C)SS2)O)(C5=CC=CC=C5N4)[C@@]67[C@@H]([C@]89C(=O)N(C(C(=O)N8[C@H]6NC1=CC=CC=C71)(SS9)C)C)O
|
|
InChI |
InChI=1S/C31H30N6O6S4/c1-5-27-23(41)37-21-29(15-11-7-9-13-17(15)33-21,19(39)31(37,47-45-27)25(43)35(27)4)28-14-10-6-8-12-16(14)32-20(28)36-22(40)26(2)34(3)24(42)30(36,18(28)38)46-44-26/h6-13,18-21,32-33,38-39H,5H2,1-4H3/t18-,19-,20+,21-,26?,27-,28-,29+,30-,31-/m0/s1
|
|
InChIKey |
BNGCIRYZSMUYSN-AVSUBWOXSA-N
|
|
Synonyms |
Sch 52901; Chaetocin, 2-de(hydroxymethyl)-19'-deoxy-2-ethyl-6,6'-dihydroxy-, (6S,6'S,7S,7'S)-; 174285-72-4
|
|
CAS | 174285-72-4 | |
PubChem CID | 132472059 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 710.9 | ALogp: | 1.5 |
HBD: | 4 | HBA: | 12 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 247.0 | Aromatic Rings: | 12 |
Heavy Atoms: | 47 | QED Weighted: | 0.34 |
Caco-2 Permeability: | -5.662 | MDCK Permeability: | 0.00001780 |
Pgp-inhibitor: | 0.972 | Pgp-substrate: | 0.044 |
Human Intestinal Absorption (HIA): | 0.405 | 20% Bioavailability (F20%): | 0.981 |
30% Bioavailability (F30%): | 0.993 |
Blood-Brain-Barrier Penetration (BBB): | 0.144 | Plasma Protein Binding (PPB): | 83.94% |
Volume Distribution (VD): | 1.002 | Fu: | 7.38% |
CYP1A2-inhibitor: | 0.02 | CYP1A2-substrate: | 0.121 |
CYP2C19-inhibitor: | 0.955 | CYP2C19-substrate: | 0.949 |
CYP2C9-inhibitor: | 0.978 | CYP2C9-substrate: | 0.101 |
CYP2D6-inhibitor: | 0.197 | CYP2D6-substrate: | 0.07 |
CYP3A4-inhibitor: | 0.959 | CYP3A4-substrate: | 0.987 |
Clearance (CL): | 7.332 | Half-life (T1/2): | 0.023 |
hERG Blockers: | 0 | Human Hepatotoxicity (H-HT): | 0.143 |
Drug-inuced Liver Injury (DILI): | 0.987 | AMES Toxicity: | 0.015 |
Rat Oral Acute Toxicity: | 0.928 | Maximum Recommended Daily Dose: | 0.873 |
Skin Sensitization: | 0.927 | Carcinogencity: | 0.541 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.004 |
Respiratory Toxicity: | 0.554 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003176 | 0.891 | D0SP3D | 0.239 | ||||
ENC004849 | 0.880 | D01TSI | 0.239 | ||||
ENC003381 | 0.859 | D0V3ZA | 0.233 | ||||
ENC003588 | 0.840 | D0E0RY | 0.229 | ||||
ENC003490 | 0.758 | D09NNH | 0.227 | ||||
ENC001500 | 0.584 | D0V9WF | 0.222 | ||||
ENC004848 | 0.576 | D0W7RJ | 0.222 | ||||
ENC003992 | 0.520 | D0J5YC | 0.218 | ||||
ENC003455 | 0.453 | D04RLY | 0.218 | ||||
ENC002358 | 0.437 | D08UMH | 0.216 |